These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18838590)

  • 1. Bacteriophage therapy and the mutant selection window.
    Cairns BJ; Payne RJ
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4344-50. PubMed ID: 18838590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutant and Recombinant Phages Selected from
    Peters TL; Song Y; Bryan DW; Hudson LK; Denes TG
    Appl Environ Microbiol; 2020 Oct; 86(22):. PubMed ID: 32887717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combatting intracellular pathogens using bacteriophage delivery.
    Goswami A; Sharma PR; Agarwal R
    Crit Rev Microbiol; 2021 Aug; 47(4):461-478. PubMed ID: 33818246
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Song Y; Peters TL; Bryan DW; Hudson LK; Denes TG
    Viruses; 2019 Dec; 11(12):. PubMed ID: 31861087
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimal bacteriophage mutation rates for phage therapy.
    Kysela DT; Turner PE
    J Theor Biol; 2007 Dec; 249(3):411-21. PubMed ID: 17904162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards Inhaled Phage Therapy in Western Europe.
    Wienhold SM; Lienau J; Witzenrath M
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30909579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Bacteriophage Cocktail Significantly Reduces
    Jakobsen RR; Trinh JT; Bomholtz L; Brok-Lauridsen SK; Sulakvelidze A; Nielsen DS
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriophages and bacterial extracellular vesicles, threat or opportunity?
    Meidaninikjeh S; Mohammadi P; Elikaei A
    Life Sci; 2024 Aug; 350():122749. PubMed ID: 38821215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-genus rebooting of custom-made, synthetic bacteriophage genomes in L-form bacteria.
    Kilcher S; Studer P; Muessner C; Klumpp J; Loessner MJ
    Proc Natl Acad Sci U S A; 2018 Jan; 115(3):567-572. PubMed ID: 29298913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phages amid antimicrobial resistance.
    Mohan Raj JR; Karunasagar I
    Crit Rev Microbiol; 2019; 45(5-6):701-711. PubMed ID: 31775552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The disparate effects of bacteriophages on antibiotic-resistant bacteria.
    Torres-Barceló C
    Emerg Microbes Infect; 2018 Oct; 7(1):168. PubMed ID: 30302018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Approaches to optimize therapeutic bacteriophage and bacteriophage-derived products to combat bacterial infections.
    Reuter M; Kruger DH
    Virus Genes; 2020 Apr; 56(2):136-149. PubMed ID: 32036540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Creation of synthetic bacterial viruses].
    Ando H
    Nihon Saikingaku Zasshi; 2018; 73(4):201-210. PubMed ID: 30487377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational models of populations of bacteria and lytic phage.
    Krysiak-Baltyn K; Martin GJ; Stickland AD; Scales PJ; Gras SL
    Crit Rev Microbiol; 2016 Nov; 42(6):942-68. PubMed ID: 26828960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ameliorating the antimicrobial resistance crisis: phage therapy.
    Saha D; Mukherjee R
    IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Back to the future: bacteriophages as promising therapeutic tools.
    Domingo-Calap P; Georgel P; Bahram S
    HLA; 2016 Mar; 87(3):133-40. PubMed ID: 26891965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phages Needed against Resistant Bacteria.
    Moelling K
    Viruses; 2020 Jul; 12(7):. PubMed ID: 32664292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review.
    Kakasis A; Panitsa G
    Int J Antimicrob Agents; 2019 Jan; 53(1):16-21. PubMed ID: 30236954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-resistance to phage infection in Listeria monocytogenes serotype 1/2a mutants.
    Trudelle DM; Bryan DW; Hudson LK; Denes TG
    Food Microbiol; 2019 Dec; 84():103239. PubMed ID: 31421769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.